Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 31.87
+0.82 (2.64%)
Jul 10, 2026, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 13.66 billion as of July 10, 2026. Its market cap has increased by 19.57% in one year.
Market Cap
13.66B
Enterprise Value
15.61B
Revenue
745.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.87
Market Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 13.66B, an increase of 39.48%. That is a compound annual growth rate of 7.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 13.66B | -11.13% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
| Jan 18, 2022 | 9.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HitGen | 14.37B |
| Anhui Anke Biotechnology (Group) | 13.72B |
| BrightGene Bio-Medical Technology | 13.57B |
| Jinyu Bio-technology | 13.31B |
| InventisBio | 12.96B |
| Staidson (Beijing) BioPharmaceuticals | 11.57B |
| Shanghai Medicilon | 11.44B |
| Inner Mongolia Furui Medical Science | 11.42B |